[1]
Oliveira, G.M. de et al. 2026. Real-world outcomes of BCL2 inhibitor-based combination therapy in myelodysplastic syndrome and acute myeloid leukemia – Experience from a university hospital in northeastern Brazil. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY. 7, 1 (Mar. 2026). DOI:https://doi.org/10.46765/2675-374X.2025v7n1e315.